Knowledge Center
Article / Jun 08, 2009
The View From New Jersey
Source:
C&EN, 8 June, 2009
In the spring of 2003, ËÄÉ«AV opened a small-scale production facility in East Windsor, N.J. As its name implies, the $20 million Technology Transfer Center was intended as a place to develop customers' molecules before moving them to headquarters in Loures, Portugal, for scale-up. Given ËÄÉ«AV's target market of small to midsized drug companies, TTC was meant to boost business with U.S. biotech firms.
Related links
Also in the Knowledge Center
Scientific Article
Scientific Article
/ Feb 08, 2010
Custom Chemicals. After struggling through 2009, contract manufacturers are honing their strategies and hoping for a better 2010
Read more
Scientific Article